Trials / Completed
CompletedNCT03447886
Understanding Barriers to Initiation and Adherence to Endocrine Therapy in Young Breast Cancer Survivors of Diverse Backgrounds
Understanding Barriers to Initiation and Adherence to Adjuvant Endocrine Therapy in Young Breast Cancer Survivors of Diverse Racial, Ethnic, and Socio-economic Backgrounds: The EMPOWER Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 17 (actual)
- Sponsor
- Dana-Farber Cancer Institute · Academic / Other
- Sex
- Female
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The overall goal of this study is to qualitatively explore how behavioral, cultural, psychosocial, and economic barriers and facilitators affect the decision to start and adhere to endocrine therapy (ET) among young breast cancer survivors of diverse racial, ethnic, and socio-economic backgrounds with hormone receptor positive (HR+) breast cancer
Detailed description
A qualitative study that will use interviews to gain an in depth understanding of factors affecting the decision to start and adhere to endocrine therapy (ET) among young breast cancer survivors of diverse racial, ethnic, and socio-economic backgrounds with hormone receptor positive (HR+) breast cancer
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Phone interview | Collecting clinical and socio-demographic information. |
Timeline
- Start date
- 2018-03-09
- Primary completion
- 2018-08-27
- Completion
- 2018-08-27
- First posted
- 2018-02-27
- Last updated
- 2021-06-11
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03447886. Inclusion in this directory is not an endorsement.